Neuroprotective Formulations Combining Antioxidants for Oxidative Stress
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neurodegenerative disorders like Alzheimer's and Parkinson's often have toxic side effects and are not effective for long-term use, and existing therapies fail to adequately address oxidative stress, which contributes to neuronal damage.
Innovation Solution
Formulations combining agents such as folate, vitamin E, acetyl-L-carnitine, N-acetyl cysteine, S-adenosyl methionine, and 3-deazaadenosine are used to reduce reactive oxygen species and inhibit neuronal loss, administered either as nutriceuticals or pharmaceuticals, which can be used alone or in combination to target multiple pathways of oxidative stress.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If single compounds are used for treatment, then the treatment mechanism is simple, but the efficacy is insufficient and toxic side effects occur
Solution Approach 1:
The patent combines multiple compounds (e.g., vitamin E, folate, acetyl-L-carnitine in nutriceutical formulations; NAC, SAM, DZA in pharmaceutical formulations) into single compositions to achieve synergistic effects. This merging approach addresses the insufficiency of single-compound treatments by targeting multiple pathological pathways simultaneously, thereby improving treatment efficacy while maintaining manageable formulation complexity through rational drug combination design.
Solution Approach 2:
The patent develops composite formulations containing multiple active ingredients with complementary mechanisms of action. These composite materials (formulations) integrate compounds that address different aspects of neurodegenerative pathology - antioxidant protection, mitochondrial function, homocysteine metabolism - creating a multi-faceted therapeutic approach that overcomes the limitations of single-compound simplicity.
2Duration of action of stationary object
If treatments are administered long-term, then preventive effect is achieved, but toxic side effects accumulate
Solution Approach 1:
The patent employs compounds at optimized concentrations and dosages that balance therapeutic efficacy with safety for long-term administration. By carefully controlling parameters such as dosage, frequency, and combination ratios, the formulations achieve sustained neuroprotective effects while minimizing toxic side effects, enabling treatment durations sufficient to address the chronic nature of neurodegenerative diseases.
Solution Approach 2:
The nutriceutical formulations use compounds with favorable safety profiles (vitamin E, folate, acetyl-L-carnitine) that can be administered long-term with minimal toxicity, effectively replacing more potent but toxic pharmaceutical options for preventive and maintenance therapy in neurodegenerative disorders.
3Reliability
If oxidative stress is not addressed, then treatment is simple, but neuronal damage progresses
Solution Approach 1:
The patent selects compounds that perform multiple functions: vitamin E provides direct antioxidant protection and membrane stabilization; folate participates in homocysteine metabolism and DNA repair; acetyl-L-carnitine supports mitochondrial energy production and acts as an antioxidant; NAC replenishes glutathione and scavenges radicals; SAM provides methyl groups for neurotransmitter synthesis and acts as an antioxidant; DZA inhibits homocysteine formation. This multi-functionality allows a single compound to address oxidative stress through multiple mechanisms, improving neuroprotection efficacy without proportionally increasing formulation complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These formulations effectively reduce oxidative stress and neuronal damage, slowing or halting the progression of neurodegenerative symptoms, improving cognitive functions, and reducing the accumulation of harmful proteins associated with neurodegenerative diseases.
Implementation Method 1
Oxidative stress plays a role in neurodegeneration... The reduction of oxidative stress is therefore a target for therapeutic interventions... These formulations inhibit the progressive loss of neurons... by reducing reactive oxygen species
Implementation Method 2
The second formulation (pharmaceutical formulation) includes two or more of N-acetyl cysteine (NAC; NALC), S-adenosyl methionine (SAM), and 3-deazaadenosine (DZA). These formulations inhibit the progressive loss of neurons... by reducing reactive oxygen species
Data Source
AI summary
Nutriceutical and pharmaceutical formulations for treating neurodegenerative disorders such as Alzheimer's disease are provided. Nutriceutical formulations include two or more of folate, vitamin E, and acetyl-L-carnitine (ALCAR). Pharmaceutical formulations include two or more of 3-deaza-adenosine (DZA), N-acetyl-L-cysteine (NAC), and S-adenosylmethionine (SAM).